Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax
The European Commission yesterday approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022.
Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023, once reviewed and approved by EMA as safe and effective. Member States will also be able to donate vaccines to lower and middle-income countries or to re-direct them to other European countries.
Yesterday's contract complements an already broad portfolio of vaccines to be produced in Europe, including the contracts with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna and the concluded exploratory talks with Valneva. It represents another key step towards ensuring that Europe is well prepared to face the COVID-19 pandemic.
The President of the European Commission, Ursula von der Leyen, yesterday said:
“As new coronavirus variants are spreading in Europe and around the world, this new contract with a company that is already testing its vaccine successfully against these variants is an additional safeguard for the protection of our population. It further strengthens our broad vaccine portfolio, to the benefit of Europeans and our partners worldwide.”
Stella Kyriakides, Commissioner for Health and Food Safety, yesterday said:
“Vaccinations in the EU are advancing and we are closer to our target of 70% fully vaccinated citizens by the end of summer. Our new agreement with Novavax expands our vaccine portfolio to include one more protein-based vaccine, a platform showing promise in clinical trials. We will continue working tirelessly to ensure that our vaccines continue to reach citizens in Europe and around the world, to end the pandemic as quickly as possible.”
Novavax is a biotechnology company developing next-generation vaccines for serious infectious diseases. Their COVID-19 vaccine is already under rolling review by EMA in view of a potential market authorisation.
The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company's experience in vaccine development and its production capacity to supply the whole of the EU.
Latest News from
Make it easier for 11 million EU citizens to participate in European elections02/12/2022 14:33:00
MEPs adopted a series of proposals to reinforce the right of mobile EU citizens to vote and stand in European elections in the EU country in which they reside.
State aid: Commission opens in-depth investigation into Lithuanian measure to compensate Litgas for operation of LNG terminal02/12/2022 13:25:00
The European Commission has opened an in-depth investigation to assess whether the compensation granted by Lithuania to Litgas UAB (‘Litgas') for supplying a mandatory quantity of liquefied natural gas (‘LNG') to the LNG terminal in Klaipėda between 2016 and 2018 is in line with EU State aid rules.
Waste shipments: stricter rules to protect the environment and human health02/12/2022 12:38:00
The Environment Committee yesterday adopted its position on revised rules governing shipments of waste to boost the EU circular economy, resource efficiency and zero pollution goals.
State aid: Commission approves €1 billion French scheme to support companies in the context of Russia's war against Ukraine02/12/2022 11:33:00
The European Commission has approved a €1 billion French scheme to support companies in the context of Russia's war against Ukraine.
Energy saving: EU action to reduce energy consumption02/12/2022 10:38:00
Saving energy is key to fighting climate change and reducing the EU's energy dependency. Find out what MEPs are doing to reduce consumption.
Investment Plan for Europe: €35 million EIB loan for Spanish company GAM to support electric rental fleets and sustainable last-mile delivery02/12/2022 09:33:00
The European Investment Bank (EIB) will lend €35 million to the Spanish multinational GAM (BME ticker: GALQ), which specialises in turnkey machinery solutions for industry, to make its rental fleet electric and develop more sustainable last-mile solutions for its subsidiary Inquieto.
MEPs adopt EU budget 2023: focus on Ukraine, energy and recovery30/11/2022 10:33:00
For next year’s EU budget, MEPs secured better and more effective support for addressing the consequences of the war in Ukraine and the pandemic recovery process.
Youth Action Plan: Council involves young people in policy-making30/11/2022 09:25:00
The Council recently (28 November 2022) approved conclusions on the Youth Action Plan for engaging young people in EU external action.
World Cup in Qatar: FIFA should help compensate families of dead migrant workers29/11/2022 16:33:00
With the 2022 FIFA World Cup having kicked off in Qatar, Parliament deplores the deaths of thousands of migrant workers ahead of the tournament.
State aid: Commission approves €557 million German support to compensate Deutsche Bahn for damages suffered by its subsidiary DB Fernverkehr due to the coronavirus pandemic29/11/2022 15:25:00
The European Commission has found a €557 million German support measure in favour of Deutsche Bahn to be in line with EU State aid rules.